Babies who are born prematurely or who experience respiratory problems shortly after birth are at risk for bronchopulmonary dysplasia (BPD), sometimes called chronic lung disease. Although most infants fully recover from BPD and have few long-term health problems as a result, BPD can be a serious condition requiring intensive medical care.
Investigators are identifying biomarkers associated with BPD in order to develop personalized therapies to prevent the disease and improve patient outcome. Collaboration within Nationwide Children’s Hospital and a unique relationship with the Antipartum Unit and the Labor and Delivery Unit at The Ohio State University Medical Center allows researchers to more easily identify eligible study participants and merge clinical and laboratory data.
Learn more about our research by visiting the Center for Perinatal Research website.